- Home
- ICG vs VSTM Comparison
ICG vs VSTM Comparison
Compare ICG & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- VSTM
- Stock Information
- Founded
- ICG 2017
- VSTM 2010
- Country
- ICG China
- VSTM United States
- Employees
- ICG N/A
- VSTM N/A
- Industry
- ICG Semiconductors
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ICG Technology
- VSTM Health Care
- Exchange
- ICG Nasdaq
- VSTM Nasdaq
- Market Cap
- ICG 559.6M
- VSTM 239.9M
- IPO Year
- ICG 2023
- VSTM 2012
- Fundamental
- Price
- ICG $4.51
- VSTM $7.00
- Analyst Decision
- ICG Strong Buy
- VSTM Strong Buy
- Analyst Count
- ICG 1
- VSTM 8
- Target Price
- ICG $11.00
- VSTM $12.00
- AVG Volume (30 Days)
- ICG 582.9K
- VSTM 2.2M
- Earning Date
- ICG 02-26-2025
- VSTM 11-06-2024
- Dividend Yield
- ICG N/A
- VSTM N/A
- EPS Growth
- ICG N/A
- VSTM N/A
- EPS
- ICG 0.11
- VSTM N/A
- Revenue
- ICG $34,648,799.00
- VSTM $10,000,000.00
- Revenue This Year
- ICG N/A
- VSTM N/A
- Revenue Next Year
- ICG $74.94
- VSTM $53.90
- P/E Ratio
- ICG $40.53
- VSTM N/A
- Revenue Growth
- ICG 202.16
- VSTM N/A
- 52 Week Low
- ICG $2.80
- VSTM $2.10
- 52 Week High
- ICG $14.22
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- ICG 47.16
- VSTM 74.23
- Support Level
- ICG $2.80
- VSTM $3.46
- Resistance Level
- ICG $7.95
- VSTM $4.27
- Average True Range (ATR)
- ICG 2.11
- VSTM 0.55
- MACD
- ICG -0.24
- VSTM 0.22
- Stochastic Oscillator
- ICG 18.51
- VSTM 93.16
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.